Patent Disputes Do Not Pay Off, Merck Says: Sweet Spot In “Bitter Medicine”
Executive Summary
Aggressive patent defensive strategies do not pay off on Wall Street, Merck CEO Ray Gilmartin told Peter Jennings during an ABC News special, "Bitter Medicine: Pills, Profit and the Public Health," which aired May 29